Nimetazepam

Nimetazepam is a benzodiazepine derivative. It is marketed under several brand names such as Erimin and Lavol. It is recognized for its hypnotic properties. Nimetazepam is also an anticonvulsant. It is sold in 5 mg tablets. It is generally prescribed for the short-term treatment of severe insomnia in patients who have difficulty falling asleep or maintaining sleep.

Etymology

The term "Nimetazepam" is derived from the elements of its chemical structure. "Nimet" is a contraction of "nitro", referring to the nitro group in its structure, and "azepam" is a common suffix for benzodiazepine drugs, referring to the azepine ring in their structure.

Pharmacology

Nimetazepam is a benzodiazepine, which means it acts on the GABA receptors in the brain. This action results in an increase in the effect of the neurotransmitter GABA, which leads to sedative, hypnotic, anxiolytic, and muscle relaxant effects.

Side Effects

Like other benzodiazepines, Nimetazepam can cause a range of side effects. These can include drowsiness, confusion, and memory impairment. Long-term use can lead to tolerance, dependence, and withdrawal symptoms on discontinuation.

Legal Status

Nimetazepam is a controlled substance in many countries due to its potential for abuse and addiction. In some countries, it is a prescription-only medication.

See Also

• Benzodiazepine
• Insomnia
• GABA

References

Nimetazepam Resources
Latest articles Most recent articles Ongoing trials	Wikipedia